Psoriatic Arthritis: 5 Things To Know About Kim Kardashian’s Illness. During an emotional episode of ‘KUWTK,’ Kim Kardashian learned that her mystery illness wasn’t lupus, but was, in fact ...

Psoriatic Arthritis. This type of arthritis often (but not always) affects people who already have psoriasis, ... Both lupus and RA can cause pain, swelling, and stiffness in your joints.

In September 2022, the FDA approved deucravacitinib for moderate-to-severe plaque psoriasis, officially introducing tyrosine kinase 2 inhibition to clinics across the United States. Hailed by its ...

Anyone can develop psoriatic arthritis, but it’s most common in people who already have psoriasis, affecting about 30 percent of people with the skin condition. Whether you’re managing just ...

Some people with rheumatoid arthritis who use GLP-1 drugs — such as Wegovy and Ozempic — have reported an improvement in the severity and frequency of their arthritic symptoms.. It has been ...

Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints at 16 weeks, according to late-breaking data presented at the American ...

Using Baseline Markers to Predict Response in Psoriatic Arthritis — More biomarker research is needed, but new study is a good start by Greg Laub , Director, Video, MedPage Today December 13, 2023 ...

In addition to psoriatic arthritis, SIT-047 also holds potential across a range of autoimmune conditions where MTHFD2 is strongly upregulated, including rheumatoid arthritis, lupus, Crohn’s ...

A new clinical trial shows potential for the drug brepocitinib to treat psoriatic arthritis, reducing symptoms by as much as 20%.

Juvenile psoriatic arthritis (JPA) is a chronic inflammatory condition affecting children under 16, characterized by joint pain, swelling, and a red, scaly rash. Around 0.5 per cent to 2.5 per ...

UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...